Gould Robert J is Interim President & CEO of Fulcrum Therapeutics Inc.
Person profile
Roles
Fulcrum Therapeutics
Interim President & CEO
Turnstone Biologics
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
3
Turnstone Biologics Corp.
20 Jul 23
4
Fulcrum Therapeutics, Inc.
29 Jun 23
4
Fulcrum Therapeutics, Inc.
13 Jan 23
4
Fulcrum Therapeutics, Inc.
29 Jun 22
4
Fulcrum Therapeutics, Inc.
8 Jun 22
4
Fulcrum Therapeutics, Inc.
6 Jun 22
4
Fulcrum Therapeutics, Inc.
11 Apr 22
4
Fulcrum Therapeutics, Inc.
5 Apr 22
4
Fulcrum Therapeutics, Inc.
17 Mar 21
4
Fulcrum Therapeutics, Inc.
18 Feb 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
27 Jun 23 | FULC Fulcrum Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 3.16 | 30,000 | 94.80 k | 30,000 |
13 Jan 23 | FULC Fulcrum Therapeutics | Common Stock | Sell | Dispose S | No | Yes | 15 | 6,766 | 101.49 k | 499,864 |